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Carbapenem-resistant determinants and their surrounding genetic structure were
studied in Acinetobacter spp. from neonatal sepsis cases collected over 7 years
at a tertiary care hospital. Acinetobacter spp. (n = 68) were identified by
ARDRA followed by susceptibility tests. Oxacillinases, metallo-β-lactamases (MBLs),
extended-spectrum β-lactamases and AmpCs, were detected phenotypically and/or
by PCR followed by DNA sequencing. Transconjugants possessing the blaNDM−1(New
Delhi metallo-β-lactamase) underwent further analysis for plasmids, integrons and
associated genes. Genetic environment of the carbapenemases were studied by PCR
mapping and DNA sequencing. Multivariate logistic regression was used to identify
risk factors for sepsis caused by NDM-1-harboring organisms. A. baumannii (72%)
was the predominant species followed by A. calcoaceticus (10%), A. lwoffii (6%), A.
nosocomialis (3%), A. junni (3%), A. variabilis (3%), A. haemolyticus (2%), and 14TU (2%).
Fifty six percent of the isolates were meropenem-resistant. Oxacillinases present were
OXA-23-like, OXA-58-like and OXA-51-like, predominately in A. baumannii. NDM-1 was
the dominant MBL (22%) across different Acinetobacter spp. Isolates harboring NDM-1
also possessed bla(VIM−2, PER−1,
′
VEB−2,CTX−M−15), armA, aac(6 )Ib, aac(6
′)Ib-cr genes.
blaNDM−1was organized in a composite transposon between two copies of ISAba125
in the isolates irrespective of the species. Further, OXA-23-like gene and OXA-58-like
genes were linked with ISAba1 and ISAba3 respectively. Isolates were clonally diverse.
Integrons were variable in sequence but not associated with carbapenem resistance.
Most commonly found genes in the 5′ and 3′conserved segment were aminoglycoside
resistance genes (aadB, aadA2, aac4′), non-enzymatic chloramphenicol resistance
gene (cmlA1g) and ADP-ribosylation genes (arr2, arr3). Outborn neonates had a
significantly higher incidence of sepsis due to NDM-1 harboring isolates than their
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inborn counterparts. This study demonstrates the significance of both A. baumannii and
other species of Acinetobacter in cases of neonatal sepsis over an extended period.
Oxacillinases and blaNDM−1 are the major contributors to carbapenem resistance. The
dissemination of the blaNDM−1 is likely linked to Tn125 in diverse clones of the isolates.
Keywords: Acinetobacter spp., ARDRA, NDM-1, OXA-23, Tn125, 5′–3′ CS, neonatal sepsis, India
INTRODUCTION
Acinetobacter, a non-fermenting Gram-negative coccobacilli, has
been noted as a pathogen in neonatal units in several parts of
the globe and outbreaks caused by this organism have also been
reported (Huang et al., 2002; Chan et al., 2007; Hammerum
et al., 2015). Though A. baumannii has been predominantly
implicated in neonatal infections or sepsis, “other species” within
the genus have also been reported to have caused sepsis in
neonates (Beaufort et al., 1999; Kilic et al., 2008).The ability of
the species to acquire antibiotic resistance has now resulted in the
acquisition of the potent carbapenem resistant gene, blaNDM−1
(Bonnin et al., 2012; Boulanger et al., 2012; Chuanfu et al.,
2013). This enzyme, New Delhi Metallo-β–lactamase-1 (NDM-
1), is an addition to the wide array of antimicrobial resistance
mechanisms that have been described for Acinetobacter spp.
There have been reports of NDM-1 in Acinetobacter from
different countries (Nordmann et al., 2011). Variants of this
enzyme from Acinetobacter have also been reported (Espinal
et al., 2011). A study has shown that blaNDM−1 is possibly a
chimera that was constructed in A. baumannii (Dortet et al.,
2014). Though most studies report the presence of this enzyme
in A. baumannii, NDM-1 has also been detected in other
species such as A. lwoffii and A. pittii (Hu et al., 2012; Pasteran
et al., 2014). Apart from NDM-1, carbapenem resistance in
Acinetobacter is mediated predominantly by the carbapenem-
hydrolyzing-oxacillinases belonging to molecular class D (OXA-
type carbapenemases) and also by other metallo-β-lactamases
(MBLs) belonging to the class B enzymes such as the IMP-and
VIM-types.
In addition to the antibiotic resistance, the identification
within this genus remains difficult (Vaneechoutte et al., 1995).
Acinetobacter genus consists of more than 30 species (Turton
et al., 2011) and identification requires molecular methods
which are not available in the clinical laboratories in developing
countries. Thus, these organisms are not identified to the
species level using appropriate methods. Until this is done, the
association of the various species to nosocomial cases can never
be achieved.
Most investigations of Acinetobacter in neonatal units have
been ad hoc studies that were triggered by an outbreak. There
is a dearth of studies that focus on neonatal infections caused
by Acinetobacter for an extended period of time. In this study
we investigate (i) the prevalence of Acinetobacter in cases of
neonatal sepsis for a period of about 7 years, (ii) the carbapenem-
resistant determinants and the genetic context of blaNDM−1
in Acinetobacter, (iii) the transmission of blaNDM−1 and (iv)
association of clinical factors with episodes of sepsis caused due
to NDM-1-harboring isolates. The emergence of NDM-1 in this
unit makes it relevant to carry out such a study. The use of
molecular methods in this study to discriminate the different
species of Acinetobacter also gives an insight about the different
species of Acinetobacter as a causative agent of neonatal sepsis.
MATERIALS AND METHODS
Setting and Patients
The specimens were collected from the neonatal intensive
care unit of the IPGMER and SSKM Hospital, Kolkata, India
from 2007(January) to 2014(June). Due to some unavoidable
circumstances specimens could not be collected from January
2012 to June 2012. This unit has a 16 bed Level III unit, 26 bed
Level II unit and 8 bed neonatal surgical units. This unit had 1185
admissions per year (departmental census 2013), including both
intramural and extramural births. Blood cultures of the neonates
having sepsis were processed by previously described methods
(Roy et al., 2013). In brief, 1 ml of blood for culture was drawn
with aseptic precautions from a peripheral vein into Peds Plus
vials. Blood culture was performed with a BACTEC9050 system
(Becton Dickinson, Sparks, MD, USA) from 2008 onwards and
manually prior to that. For any culture that flagged positive,
Gram-staining was performed and subculture was done on
appropriate media based on Gram’s stain: MacConkey agar
(Difco Laboratories, Detroit, MI, USA) and 5% sheep blood
agar (Difco Laboratories) for Gram-negative and Gram-positive
organisms, respectively. Clinical data were collected from the
hospital registers.
Identification of Acinetobacter
The identity of the Acinetobacter spp. was confirmed by VITEK 2
compact system (BioMérieux, Marcy l’Etoile, France) from 2012
onwards and prior to that by the Mini API system (BioMérieux).
Molecular identification of all Acinetobacter spp. was carried out
by the ARDRA (amplified ribosomal DNA restriction analysis)
method (Dijkshoorn et al., 1998).
Antimicrobial Susceptibility and MIC
Antimicrobial susceptibility testing was done by the VITEK
2 compact system (BioMérieux) and results were interpreted
according to the custom set parameters (CLSI, 2014, FDA
guidelines and natural resistance interpretation).
The MIC values (mg/L) of meropenem and ceftazidime were
also determined using Etest method (AB Biodisk, Solna, Sweden)
and were interpreted according to CLSI (CLSI, 2014). The MIC50
and MIC90 for meropenem and ceftazidime were calculated as
the MIC at which 50 and 90% of the isolates were inhibited.
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Detection of β-Lactamase and
Carbapenemase Phenotypes
The production of ESBL, MBL, AmpC was detected by the
commercial diagnostic tablets (Rosco Diagnostica A/S, Taastrup,
Denmark) following the manufacturer’s instructions. The results
were interpreted as follows: an increase in ≥5 mm of inhibition
zone diameter around boronic acid and dipicoloinic acid,
in comparison to the diameter with meropenem alone was
considered a positive result for AmpC and MBL respectively,
while an increase in ≥5 mm in diameter around clavulanic
acid and cloxacillin against cefotaxime alone suggests ESBL and
AmpC production respectively (Giske et al., 2010).
Detection of Carbapenemases, AmpCs
and ESBLs by Genotypic Method
PCR was carried out for carbapenem-resistant
genes (blaVIM,IMP,SPM−1,GIM−1,SIM−1,NDM, and
blaOXA−23−like,OXA−24−like,OXA−51−like,OXA−58−like) (Ellington
et al., 2007; Roy et al., 2011a; Datta et al., 2014) extended-
spectrum-β-lactamase genes (blaCTX−M,VEB,PER) (Cao et al.,
2002; Saladin et al., 2002; Colom et al., 2003; Woodford et al.,
2006) and blaAmpC genes (Perilli et al., 2007) (Table S1).
Class 1 and class 2 integrons (Corvec et al., 2003; Shibata et al.,
2003), plasmid-mediated quinolone resistance genes aac(6′)-Ib-cr
and aminoglycoside resistance genes (rmtA, rmtB, rmtC, rmtD,
and armA) (Berçot et al., 2011) were additionally investigated in
the NDM-1-producing isolates (Table S1).
Conjugation and Electro-Transformation of
blaNDM-1
Conjugal transfer of blaNDM−1 to the sodium azide-resistant E.
coli J53 recipient (Pasteran et al., 2014) was attempted by a
solid mating assay (Walsh et al., 2011). Transconjugants were
selected with varying concentrations of meropenem (0.1–2mg/L)
and 100 mg/L of sodium azide. Electro-transformation into
commercially available MAX Efficiency R© DH10BTM Competent
Cells (Life Technologies, Carlsbad, CA, USA) was carried out for
non-conjugative strains using 0.1 mg/L meropenem.
Susceptibility test for ceftazidime and meropenem was
performed for the blaNDM−1 carrying transconjugants and
transformants by Etest method and was followed by PCRs.
Plasmid Characterization
Plasmids harbored by the donor (blaNDM−1-harboring isolates),
transconjugants or transformants were purified by Kado and Liu
method, 1981 andwere subsequently assessed for the number and
sizes (approx) using E. coliV517 and S. flexneri 2a YSH6000 (Roy
et al., 2011b) as mega-plasmid marker (Kado and Liu, 1981).
Sequencing of the Amplified Product
Amplified products of blaNDM, blaVIM, blaVEB, blaPER, blaAmpC,
blaCTX−M were sequenced directly on both strands using Big
dye Terminator v3.1 Cycle Sequencing Kit and analyzed with
an automated sequencer (ABI 3730 DNA Analyzer, Perkin
Elmer, USA). The blaNDM in some isolates could not be directly
sequenced and were cloned into a TOPO TA cloning vector (Life
technologies) and sequenced with the M13 primers.
Characterization of Integrons
Integrons were amplified and sequenced with primers derived
from the 5′ and 3′ conserved segments (Novais et al., 2006) and
submitted to the INTEGRALL database (http://integrall.bio.ua.
pt) for nomenclature. Some of the large products (>1500 bp)
were sequenced by primer walking technique (Sverdlov and
Tatyana, 2005).
Genetic Environment of the
Carbapenem-Resistant Genes
The genetic structures surrounding the blaNDM−1, were studied
by PCR mapping and DNA sequencing using primers based on
previously reported structures (Poirel et al., 2011; Bonnin et al.,
2012; Table S1). In the NDM-1-possessing transconjugants and
transformants, the proximity of the IS elements to genes were
determined using combinations of the respective IS primers and
the OXA-23-like and OXA-58-like primers (Lin et al., 2010).
Pulsed Field Gel Electrophoresis (PFGE)
PFGE was carried out for all isolates in a CHEF-DR III apparatus
(Bio-Rad Laboratories, Hercules and CA) by ApaI enzyme (Abbo
et al., 2005) (New England Biolab, Massachusetts).
When indistinguishable isolates of Acinetobacter spp. were
cultured from two or more neonates treated in the NICU during
an interval of up to 15 days, they were considered as a single
episode of cross-transmission (Roy et al., 2010).
Statistical Analysis
The data for the 68 neonates along with all their recorded
variables (clinical factors, results of tests, organisms found,
antibiotic resistance patterns etc.) were entered in IBM SPSS
Statistics Version 20.0 and analyzed systematically using
established statistical procedures. Characteristics were described
as median and standard deviation (SD) for continuous
variables and as frequencies and percentages for categorical
variables.
Features like sex, gestational age, birth weight, mode of
delivery, use of mechanical ventilator and place of birth
(intramural or extramural) that are known to be associated
with sepsis were analyzed for association with episodes of
sepsis caused due to NDM-1-harboring isolates. Multivariate
logistic regression was used to identify the risk factors for
infection by NDM-1-harboring organisms. All available clinical
factors were entered into the regression simultaneously and
a backward selection process was used to identify the risk
factors. All relationships were evaluated at a 95% significance
level.
Chi-square test of independence was carried out to determine
the association of sepsis due to NDM-1 with outcome (death
or discharge) and onset of sepsis (early or late). Finally,
a simple t-test of proportions was used to test if the
incidence of infection via Acinetobacter baumannii or other
species was significantly different for each type of antibiotic
resistance. All these tests were evaluated at a 95% significance
level.
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RESULT
Demographics of the Neonates
Twenty out of 68 (29.4%) neonates from whom Acinetobacter
spp. was isolated were female while 46 were male (gender
information was missing for 2 neonates). The median gestational
age for the neonates was 32.5 weeks (SD 3.4 weeks) and median
birth weight was 1363 grams (SD 828 grams). Eighty two percent
(56 of 68) of the neonates were pre-term while 77.9% (53 of 68)
of the neonates were of low birth weight. Sixty five percent (44
of 68) of the neonates were delivered by cesarean section while
the rest had a normal vaginal delivery. Most of the neonates in
this unit were born at the facility (inborn)—46 of 68 (67.6%)
and the rest were born at other facilities and later transferred
to this unit (out born). Sixty two percent of the neonates had
early onset sepsis while 31% had late onset of sepsis (time
of onset of sepsis could not be recorded with certainty for 5
neonates).
Identification of Acinetobacter spp. by
ARDRA
During this period, 68 non-duplicate Acinetobacter spp. were
isolated from the blood specimens of 68 septicaemic neonates.
All isolates were analyzed in this study. The year-wise breakup
of the isolates is depicted in Figure S1 indicating the higher
prevalence of Acinetobacter calcoaceticus-baumannii complex
(ACB complex) comprising of A. baumannii, A. calcoaceticus, A.
nosocomialis, and A. pittii.
Each of the 68 isolates was unambiguously identified to
the species level by ARDRA. The predominant species was A.
baumannii (72%) followed by A. calcoaceticus (10%), A. lwoffii
(6%), A. nosocomialis (3%), A. junni (3%), A. variabilis (3%), A.
haemolyticus (2%), and 14TU (2%) (Table 1).
The identity of the isolates using the ARDRA method was
compared with Mini API or VITEK 2 results. Twenty six of the
38 strains were identified as the same species when results of the
mini API and ARDRA (Table S2) were compared. Similarly, 19
of the 30 isolates were assigned as the same species by VITEK 2
and ARDRA (Table S2).
Antimicrobial Susceptibility Tested by
VITEK 2
Table 1 summarizes the antibiotic resistance pattern found in
Acinetobacter spp. during this period. More than 75% isolates
were resistant to extended spectrum cephalosporins (79% isolates
were resistant to ceftazidime, 75% isolates were resistant to
cefepime), 85% isolates were resistant to aztreonam, 50% were
resistant to doripenem, 51% were resistant to both imipenem and
meropenem. More than 60% isolates were resistant to at least
one aminoglycosides (60% resistant to amikacin, 71% resistant
to gentamicin). Eighty four percent isolates were resistant to
ciprofloxacin. But all isolates showed high susceptibility to
minocycline (99%) and tigecycline (100%).
All the Acinetobacter isolates were categorized into two
groups, the ACB complex (A. baumannii, A. calcoaceticus, A.
nosocomialis, and A. pittii) and other species (A. lwoffii, A. junni,
A. haemolyticus, A. variabilis, and 14TU). Several analyses in this TA
B
L
E
1
|
A
n
ti
b
io
ti
c
s
u
s
c
e
p
ti
b
il
it
y
p
a
tt
e
rn
(b
y
V
IT
E
K
2
c
o
m
p
a
c
t)
a
n
d
g
e
n
e
ti
c
d
e
te
rm
in
a
n
ts
o
f
A
c
in
e
to
b
a
c
te
r
s
p
p
.
O
rg
a
n
is
m
(n
)/
A
n
ti
m
ic
ro
b
ia
l
a
g
e
n
t
(o
v
e
ra
ll
%
)
N
o
.
o
f
re
s
is
ta
n
t
is
o
la
te
s
(%
o
f
th
e
re
s
is
ta
n
t
is
o
la
te
s
)
G
e
n
e
ti
c
d
e
te
rm
in
a
n
ts
(%
o
f
is
o
la
te
s
)
C
A
Z
(7
9
.4
%
)
F
E
P
(7
5
%
)
A
Z
T
(8
5
.2
%
)
D
O
R
(5
0
%
)
IM
P
(5
1
%
)
M
E
M
(5
1
%
)
A
N
(6
0
%
)
G
E
N
(7
0
.8
%
)
C
IP
(8
3
.8
%
)
M
IN
(1
%
)
T
G
C
(0
%
)
b
la
N
D
M
-1
(2
2
%
)
b
la
A
m
p
C
(5
1
.5
%
)
b
la
V
E
B
-2
(1
0
%
)
b
la
o
x
a
-5
1
-
li
k
e
(7
2
%
)
b
la
o
x
a
-2
3
-l
ik
e
(4
8
.5
%
)
b
la
o
x
a
-5
8
-
li
k
e
(1
4
.7
%
)
b
la
P
E
R
-1
(3
5
.2
%
)
1
.
A
c
in
e
to
b
a
c
te
r
c
a
lc
o
a
c
e
ti
c
u
s
-
b
a
u
m
a
n
n
ii
c
o
m
p
le
x
(A
C
B
c
o
m
p
le
x)
(5
8
)
7
9
.3
%
7
5
.8
%
8
4
.4
%
5
5
.1
%
5
5
.1
%
5
5
.1
%
6
3
.8
%
7
4
.1
%
8
6
.2
%
2
%
0
%
2
0
.6
%
5
8
.6
2
%
3
.0
4
%
8
4
.4
%
5
5
.2
%
1
5
.5
%
3
8
%
a
)
A
.
b
a
u
m
a
n
n
ii(
4
9
)
4
1
4
1
4
6
2
9
2
9
2
9
3
4
4
0
4
5
1
0
6
2
7
1
4
9
3
1
5
1
5
b
)
A
.
c
a
lc
o
a
c
e
ti
c
u
s
(7
)
4
2
2
3
3
3
3
3
5
0
0
4
4
−
−
−
3
4
c
)
A
.
n
o
s
o
c
o
m
ia
lis
(2
)
1
1
1
0
0
0
0
0
0
0
0
2
2
1
−
1
1
1
2
.
O
th
e
r
sp
e
c
ie
s(
1
0
)
a
)
A
.
lw
o
ffi
i(4
)
8
0
% 4
7
0
% 4
9
0
% 4
2
0
% 0
3
0
% 1
3
0
% 1
4
0
% 1
5
0
% 2
7
0
% 4
0
% 0
0
% 0
3
0
% 2
2
0
% 1
5
0
% 3
0
%
−
1
0
% 1
1
0
% 1
4
0
% 3
b
)
A
.
ju
n
n
ii(
2
)
2
1
2
0
0
0
1
0
1
0
0
−
1
2
−
−
−
0
c
)1
4
T
U
(1
)
−
−
1
−
−
−
−
1
−
−
−
−
−
−
−
−
−
0
d
)
A
.
va
ri
a
b
ili
s
(2
)
1
1
1
1
1
1
1
1
1
0
0
−
−
−
−
−
−
1
e
)
A
.
h
a
e
m
o
ly
ti
c
u
s
(1
)
1
1
1
1
1
1
1
1
1
0
0
1
−
−
−
−
−
0
P
-v
a
lu
e
0
.9
6
0
1
2
0
.6
8
9
1
6
0
.6
5
2
7
2
0
.0
4
0
3
6
0
.1
4
1
5
6
0
.1
4
1
5
6
0
.1
5
5
6
0
.1
2
1
1
4
0
.1
9
7
0
6
0
.6
7
4
4
8
–
–
–
–
–
–
–
–
C
A
Z
,
C
e
ft
a
zi
d
im
e
;
F
E
P,
C
e
fe
p
im
e
;
A
Z
T,
A
zt
re
o
n
a
m
;
D
O
R
,
D
o
ri
p
e
n
e
m
;
IM
P,
Im
ip
e
n
e
m
;
M
E
M
,
M
e
ro
p
e
n
e
m
;
A
N
,
A
m
ik
a
c
in
;
G
E
N
,
G
e
n
ta
m
ic
in
;
C
IP
,
C
ip
ro
flo
xa
c
in
;
M
IN
,
M
in
o
c
yc
lin
e
;
T
G
C
,
T
ig
e
c
yc
lin
e
.
S
ig
n
ifi
c
a
n
t
p
-v
a
lu
e
is
u
n
d
e
rl
in
e
d
.
Frontiers in Microbiology | www.frontiersin.org 4 August 2016 | Volume 7 | Article 1126
Chatterjee et al. Prevalence of Oxacillinases, NDM-1 in Acinetobacter
study were done where comparison between these two groups
were made.
While analyzing resistance to different groups of antibiotics
against these two categories, differences were noted for
doripenem (Table 1).The percentage of doripenem-resistant
isolates was significantly higher in ACB complex (55%)
than in other species (20%) (p-value 0.0404). However,
since the number of strains in the category “other
species” is small (n = 10), these differences should not be
overemphasized.
Distribution of MIC Values of Different
Groups of Antibiotics
There was a marked increase in resistance to carbapenems
among Acinetobacter spp. from 25% in 2007 to 87% in 2013
(Figure S1).The range of MIC values for meropenem and
ceftazidime over this period were 0.025− ≥32mg/L and
1− ≥256 mg/L respectively. For individual years, the range of
MIC values is depicted in Table S3.
Over this period the MIC50 and MIC90 values for meropenem
were 32mg/L and for ceftazidime were 256mg/L. Detailed
year-wise distribution of MIC50 and MIC90 values (mg/L) for
meropenem and ceftazidime is shown in Table S3. This result
depicted a significant increase in MIC value of meropenem
since 2011 whereas for ceftazidime high resistance persisted
throughout this period (except for 2010) (Table S3).
Detection of Different β-Lactamases by
Phenotypic Test
Of the 68 isolates, 19, 24, and 28% showed phenotypic evidence of
MBLs, ESBLs and AmpCs respectively. Among MBL-producers
(n = 13), 50% isolates showed ESBL and AmpC phenotype
both and 64% showed only ESBL phenotype. Whereas, among
non-MBL (n = 55) phenotype, 18% were ESBL producers, 27%
were AmpC producers and 11% produced both of the enzymes.
Presence of MBL sometimes complicates the detection of ESBLs
and AmpCs. Therefore, the presence of ESBLs and AmpCs in
these isolates was confirmed by PCR subsequently.
Genotypic Distribution of Various
β-lactamases
Isolates possessed different β-lactamases such as ESBLs
(50%), AmpC (52%), and carbapenemases (56%, includes
both oxacillinases and MBLs).Sequencing revealed the
predominant presence of blaPER−1(35%), followed by blaVEB−2
and blaCTXM−15. Among the carbapenem-resistant determinants
the blaOXA−23−like gene (49%) was the most common, followed
by blaOXA−58−like gene (15%). Sequence analysis revealed that
NDM-1 was the predominant (22%) MBL detected (Table 1). No
other variant of NDM was found.
Detailed distribution of these genes in the different
species has been presented in Table 1. blaNDM−1 was
present in 21% of the ACB complex (A. calcoaceticus, A.
baumannii, A. nosocomialis) and 30% of the other species (A.
haemolyticus, A. lwoffii). In contrast, most of the oxacillinases
were confined within ACB complex except 2 isolates of
A. lwoffii carried either blaOXA−23−like or blaOXA−58−like
gene.
While correlating the phenotypic and genotypic test results
of all the strains, it was observed that one strain that could
not be detected as MBL producers by phenotypic tests harbored
blaNDM−1 (A_134) as detected by PCR. Similarly, there were
8 strains which did not show the presence of ESBL by the
phenotypic tests but harbored blaPER−1 or blaCTXM−15. Of
these 8 strains, 3 showed the presence of NDM-1. Similarly,
17 of the AmpC non-producers (as tested by the phenotypic
tests) harbored blaAmpC gene and 5 of these strains also
possessed NDM-1. This showed the failure to detect ESBLs
and AmpCs by phenotypic tests particularly in MBL–producing
strains.
Diversity of the Acinetobacter Isolates
The analyses of the pulsotypes were done separately for A.
baumannii, A. calcoaceticus, and A. lwoffii. Strains of A.
baumannii were primarily diverse and dissemination of any
particular clone was not evident (Figure 1). One sporadic
case of cross-transmission was seen: A_151 (DOB 10/01/2013)
and A_153 (DOB 24/01/2013). A few pairs of strains were
found to be indistinguishable but could not be considered
as episodes of cross-transmission as they were isolated from
neonates who were not treated in the NICU during an interval
of 15 days (Figure 1). In A. calcoaceticus and A. lwoffii group
no cross-transmission was noted and all the isolates were
distinct.
The number of isolates in other groups (A. junni, A.
nosocomialis, 14TU, A. variabilis, A. haemolyticus) was small
for cluster analysis and were visually analyzed. All were
diverse.
Characterization of the blaNDM-1-Harboring
Isolates
Twenty two percent (n = 15) of the isolates harbored NDM-1
across all species of Acinetobacter. The presence of NDM-1 was
not significantly different between the ACB complex and the
other species (p-value: 0.7640). Most of the isolates (n = 11)
harboring NDM-1 had an MIC value ≥32mg/L for meropenem
except for a few that had low MIC values (0.125, 0.25, 0.5,
1 mg/L) (Table 2). One of the isolates, A_117 (0.5mg/L) had
at least three carbapenem resistant determinants blaNDM−1,
blaOXA−23−like and blaVIM−2gene. All NDM-1-harboring isolates
were resistant to a series of antibiotics except tigecycline
and colistin.
Most isolates that possessed blaNDM−1 also possessed
blaOXA−23−like or blaOXA−58−like. NDM-1 possessing isolates
also harbored blaVIM−2 (6%)′ blaVEB−2 (20%), blaPER−1 (60%),
blaAmpC (60%), armA (47%), aac(6
′)-Ib (27%). Presence of class
1 integron was observed in 8 of the NDM-1-possessing isolates;
IntI2 was present in one isolate (Table 2).
PFGE of the A. baumannii and A. calcoaceticus isolates
possessing NDM-1 revealed that diverse clones of these species
harbored NDM-1(Figure 1). No cases of cross-transmission were
noted in the NDM-1 isolates.,
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Characterization of the blaNDM-1-Harboring
Transconjugants
Fourteen of the 15 NDM-1 harboring isolates were able to
transfer blaNDM−1 by conjugation (13/15) or transformation
(1/15) to the recipients. Fifty percent of the transconjugants
showed MIC values of ≥3 mg/L for meropenem and 79% of
the isolates were also resistant to ceftazidime (MICs ≥ 8 mg/L).
One transformant (A_139-DH10B/EC) was sensitive to both
meropenem (0.023mg/L) and ceftazidime (0.5 mg/L) (Table 3).
A single plasmid was detected in all of the blaNDM−1-harboring
transconjugants and the sizes of these plasmids ranged between
86 and 213 kb (Table 3).
Investigation of the immediate genetic environment of
blaNDM−1 gene revealed the presence of a conserved structure
that always associates with the complete transposon, Tn125.
This structure starts with one copy of the ISAba125 at the 5′
end of blaNDM−1 gene and bleMBL gene followed by trpF, tat,
cutA1, groES, groEL, insE, and ISAba125 at the 3′ end. All strains
showed similar genetic structure surrounding the blaNDM−1.
As the primer walking and PCR results were consistent for
all transconjugants, sequences were thoroughly analyzed for 4
isolates (Figure 2).
PCRs were also carried out to map the position of
the respective IS elements with the blaOXA−23−like and
blaOXA−58−like genes in the transconjugants harboring NDM-1.
Among the NDM-1-harboring transconjugants, three possessed
blaOXA−23−like and three others harbored blaOXA−58−like gene
(Table 3). All transconjugants with blaOXA−23−likewere linked
to ISAba1 and all three isolates with blaOXA−58−likewere linked
to ISAba3 (Figure 2). Sequence analysis revealed the presence
of different variants of OXA-23-like enzymes, i.e., OXA-73
(A_134), OXA-225 (A_140), and OXA-171(A_148). Similarly,
blaOXA−58−like genes were identified as OXA-96 (A_114, A_156)
and OXA-164 (A_136) (Table 3).
Analysis of the integrons revealed different combinations of
resistance genes bracketed between the 5′ and 3′ conserved region
and each of these different resistance gene cassettes are presented
in Figure 3. Most commonly found genes in this conserved
segment were aminoglycoside resistance (aadB, aadA2, aac4′),
non-enzymatic chloramphenicol resistance gene (cmlA1g) and
ADP-ribosylation gene (arr2, arr3).
Association of Clinical Factors and
Mortality of the Neonates with the
Presence of NDM-1-Harboring
Acinetobacter
The results of a comparison of neonates with sepsis caused due to
NDM-1-harboring Acinetobacter with those without NDM-1 is
shown inTable 4. Multivariate logistic regression established that
neonates who were outborn had a significantly higher incidence
of NDM-1 harboring isolates than their inborn counterparts
[Odds Ratio (OR) 2.39; p-value <0.001]. None of the other
factors were found to be statistically significant.
Incidence of NDM-1 in late onset sepsis cases (38.1%) was
significantly higher than those in early onset sepsis (12.2%)
[OR 4.43; p < 0.0177].Finally, the association analysis between
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FIGURE 2 | (A) Schematic representation of Tn125 carrying blaNDM−1 gene in a representative transconjugant. Genes and their transcription orientation are indicated
by arrows. The lengths of the target genes and their exact location of the target genes are not to scale. Gene names are abbreviated according to the corresponding
proteins (Bonnin et al., 2012): cutA1 for divalent cation tolerence protein; groES, groEL for heat-chaperonin protein; insE for ISCR21 of tnpA family. 1 pac for
truncated phospholipid acetyltransferase. IRL and IRR are for inverted repeat left and right, respectively. This structure was found in all of the transcojugants (except
one transformant). (B) Diagram showing the linkage between blaOXA−58−like with ISAba3 (A_114-J53, A_136-J53, and A_156-J53). (C) Diagram showing the linkage
between blaoxa−23−like with ISAba1 (A_134-J53, A_140-J53, and A_148-J53).
FIGURE 3 | Schematic diagram of genes in between 5′CS and 3′CS of class 1 integron of 8 transconjugants of Acinetobacter spp. Three of the
transconjugants (A_134-J53, A_137-J53, and A_156-J53) share similar structure. The genes are not to scale and vertical lines represent the boundaries of each gene.
Gene names are abbreviated according to their corresponding proteins: aadB, aadA2, aacA4′− resistance to trimethoprim, gcuF, gcuE2, gcu8- unknown ORF, arr3,
and arr2- ADP-ribosylation gene, carb-2- resistance to β-lactamases. attC site- attachment sites of each gene.
NDM-1-harboringAcinetobacter isolates andmortality (18.8% in
death cases vs. 21.7% in discharge cases), showed no statistically
significant difference [p-value 0.8003].
DISCUSSION
The data show that the potential impact of Acinetobacter sepsis
on neonates in a tertiary care center is significant. There
has been an increase of sepsis due to lactose non-fermenting
Gram-negative bacteria in recent years and Acinetobacter is
an important contributor to this burden (Viswanathan et al.,
2014). This study also shows that though A. baumannii is
still by far the most common of the Acinetobacter species
causing sepsis in this unit, other species are also emerging in
the clinical settings. Though infections due to other species
of Acinetobacter has been reported (Turton et al., 2011; Tien
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et al., 2012), infection in the neonatal population caused by
species of Acinetobacter other than A. baumannii are rare.
The use of the ARDRA method in this study has helped in
the elucidation of the species providing an insight about the
presence of the other species of Acinetobacter in cases of neonatal
septicaemia.
Another issue that emerges from the study is drug resistance.
Carbapenem resistance is high and the clinician is left with very
little choice of antibiotics. The only antibiotic that still retains
activity is tigecycline, an observation that has also been made
by other authors (Golanbar et al., 2011; Hsieh et al., 2014). In
this unit, piperacillin/tazobactum and amikacin are being used
as a pre-emptive (first line) therapy for clinically suspected cases
of sepsis. As a second line of therapy ofloxacin and amikacin
are used in the unit. In rare cases where the above therapies
are ineffective and the antibiogram results are still awaited,
meropenem is used.
Further, this study also shows that the phenotypic detection
of ESBLs and AmpCs in presence of MBLs is challenging. The
failure to detect the ESBLs in theMBL–producing clinical isolates
may lead to the hidden spread of such β-lactamases complicating
the situation even further. The authors have recently devised a
method to circumvent this problem (Datta et al., 2015).
Resistance to carbapenems and cephalosporins could be
correlated to the diverse repertoire of genetic determinants
that were identified. The most prevalent were the oxacillinases.
Among the transmissible oxacillinases, OXA-23-like was the
most common and this result is confirmatory of other studies
(Woodford et al., 2006; Golanbar et al., 2011). The presence of
the oxacillinases was significantly higher in the ACB complex
compared to the other Acinetobacter species. The presence of
ESBLs like PER-1, VEB-2 and CTXM-15 were also noted along
with the carbapenemases in some isolates but compared to the
carbapenemases their numbers were lower (Ben et al., 2011). Of
the class B β-lactamases, only NDM-1 andVIM-2 were identified.
Most earlier reports of NDM-1 or a variant of the gene in clinical
settings have been in A. baumannii (Wang et al., 2007; Boulanger
et al., 2012; Revathi et al., 2013) but the presence of NDM-1 in
this study was noted across other species of Acinetobacter along
with A. baumannii.
PFGE revealed that NDM-1 harboring isolates were
diverse. Acinetobacter spp. possessing NDM-1 was isolated
predominantly from neonates delivered at other (extramural)
centers reflecting the dissemination of this gene but not any
clone in particular. A study with A. baumannii isolates collected
across Europe also reported diversity of clones in Acinetobacter
infection (Bonnin et al., 2012). Studies that have reported the
presence of NDM-1 in other genuses have also described similar
diversity of clones (Pasteran et al., 2014).
The blaNDM−1 gene was organized in a composite transposon
bracketed between two copies of ISAba125 in all the isolates
irrespective of the species. This arrangement of the gene in
Acinetobacter has been reported earlier (Pfeifer et al., 2011;
Bonnin et al., 2012; Fu et al., 2012). The similar organization
of the blaNDM−1 in the diverse clones of A. baumannii and
also the other species lends credence to the hypothesis that the
current dissemination of the gene inAcinetobacter is likely linked
TABLE 4 | Association of clinical factors with sepsis caused by
NDM-1-harboring Acinetobacter spp. in neonates.
Clinical factors Neonates
with NDM-1
(n = 15)$
Neonates
without NDM-1
(n = 53)#
P-value
No. of Neonates n % n %
Sex Male 8 18.2 36 81.6 –
Female 5 27.8 13 72.7
Gestational
Age
Pre-term 11 20.8 42 79.2 –
Term 2 22.2 7 77.8
Inborn/
Outborn
Inborn 7 16.3 36 83.7 >0.001**
Outborn 6 31.6 13 68.4
Birth Weight Low birth weight 10 20 40 80 –
Normal birth weight 3 25 9 75
Baby on
Ventilation
Yes 8 20 32 80 –
No 5 22.7 17 77.3
Mode of
Delivery
Caesarean delivery 8 19.5 33 80.5 –
Normal vaginal
delivery
5 23.8 16 76.2
#No clinical data was available for four patients.
**Significant at 95% confidence.
$No clinical data was available for two patients.
to Tn125 and not plasmids. The linkage of blaOXA−23−like and
blaOXA−58−like to ISAba1 and ISAba3 respectively as observed
here, has also been reported in several earlier studies. This shows
that the genetic context of these genes in Acinetobacter remain
similar even in geographically distant places (Chen et al., 2010;
Lin et al., 2010).
Analysis of the class I integron showed that though there was
variability in the genetic determinants present between the 5′
and 3′ CS segments, most of the genes were not associated with
carbapenem or cephalosporin resistance (except carb-2/A_157).
A few isolates harboring NDM-1 and oxacillinases had
low MIC values (even as low as 0.125 mg/L in one isolate).
Similar observation was also reported from earlier studies (Datta
et al., 2014; Zmarlicka et al., 2015). Further work is needed to
understand the reason for such differences which can occur due
to alterations in the expression of the enzymes or other changes
in the mechanism of resistance toward β-lactamases.
Statistical analysis indicated that a neonate born in other
facilities (outborn) had a significantly higher incidence of NDM-
1 harboring isolates than neonates born at this center. This
indicates the possibility of the neonates having acquired NDM-
1-harboring isolates from other hospitals where they were born.
This is supported by the fact that most had a late onset of sepsis,
the initial infection probably having acquired from the other
hospitals. The clonal diversity of the isolates also lends support
to this possibility.
This study documents the significance of both Acinetobacter
baumannii and the other species, in cases of neonatal sepsis in a
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unit over a period of 7 years. We have been able to gain a unique
assessment of the diverse genetic determinants responsible for
carbapenem resistance in these isolates. The genetic context
of the carbapenem-resistant genes also provides insight about
the importance of the ISAba125 in the spread of NDM-1 in
Acinetobacter. The emergence of NDM-1 among an already
existing repertoire of oxacillinases is a challenge for clinicians and
microbiologists alike. As new resistance mechanisms constantly
evolve, both laboratory detection systems and infection control
measures need to be enhanced.
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